Cargando…
Radiotherapy as an immune checkpoint blockade combination strategy for hepatocellular carcinoma
In the immune oncology era, the clinical efficacy of immune checkpoint inhibitors (ICIs) against most solid cancers is well known. In hepatocellular carcinoma, the recent success of combination therapy with targeting agents has accelerated the search for novel combination strategies. Radiotherapy (R...
Autores principales: | Lee, Byung Min, Seong, Jinsil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968135/ https://www.ncbi.nlm.nih.gov/pubmed/33776363 http://dx.doi.org/10.3748/wjg.v27.i10.919 |
Ejemplares similares
-
Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy
por: Li, Si-Qi, et al.
Publicado: (2022) -
Hallmarks of response to immune checkpoint blockade
por: Cogdill, Alexandria P, et al.
Publicado: (2017) -
Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
por: Lee, Yun Hua, et al.
Publicado: (2020) -
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
por: Choi, Changhoon, et al.
Publicado: (2019) -
Challenge and Hope in Radiotherapy of Hepatocellular Carcinoma
por: Seong, Jinsil
Publicado: (2009)